Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
Last trade$8.69
Day change-$0.255 (-2.85%)
Day range$8.68 – $9.01
Volume4,420,102
Market cap$1.78B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.78B
Price / earnings
—
Price / book
1.32×
Price / sales
0.5×
EV / sales
1.06×
EV / EBITDA
7.39×
Profitability
Earnings per share
-$0.61
Return on assets
-2.33%
Return on equity
-8.93%
Dividend yield
3.59%
Liquidity and leverage
Debt / equity
1.62×
Current ratio
1.63×
Quick ratio
1.04×
Cash ratio
0.16×
Cash flow
Price / cash flow
6.56×
Price / free cash flow
17.32×
Free cash flow
$103M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for XRAY, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$836M
$898M
$880M
$961M
$904M
$936M
$879M
$905M
Cost of revenue
$393M
$405M
$453M
$518M
$463M
$446M
$413M
$459M
Gross profit
$443M
$493M
$427M
$443M
$441M
$490M
$466M
$446M
Selling, general and administrative
$363M
$364M
$351M
$383M
$355M
$342M
$358M
$401M
Research and development
$42M
$45M
$44M
$40M
$37M
$37M
$36M
$42M
Total operating expenses
$406M
$411M
$462M
$582M
$659M
$618M
$403M
$955M
Operating income
$37M
$82M
-$35M
-$139M
-$218M
-$128M
$63M
-$509M
Interest expense
-$25M
-$22M
-$24M
-$22M
-$23M
-$24M
-$19M
-$16M
Income before taxes
$26M
$72M
-$42M
-$147M
-$230M
-$153M
$44M
-$523M
Income taxes
$29M
$36M
-$32M
-$2M
$198M
-$109M
$25M
-$95M
Net income
-$3M
$36M
-$10M
-$145M
-$428M
-$44M
$19M
-$428M
Net income attributable to common shareholders
-$2M
$37M
-$10M
-$146M
-$427M
-$45M
$20M
-$430M
EBITDA
$120M
$169M
$111M
$113M
$141M
$199M
$151M
$91M
Basic earnings per share
-$0.01
$0.18
-$0.05
-$0.73
-$2.14
-$0.22
$0.10
-$2.16
Diluted earnings per share
-$0.01
$0.18
-$0.05
-$0.73
-$2.14
-$0.22
$0.10
-$2.18
Recent news
Company coverage with links to the original publishers.
Dentsply Sirona lowered its full-year 2026 sales guidance to $3.5 billion and reduced adjusted EPS to $1.20-$1.30 due to weakness in dental equipment demand and higher distribution costs. The company is investing heavily in clinical education programs in North America and building sales teams for dental support organizations. Wellspect Healthcare showed positive momentum with 10% revenue growth to $92 million, while management prioritizes debt reduction alongside disciplined reinvestment in commercial execution.
Three companies have been added to the Zacks Rank #5 (Strong Sell) list today due to downward revisions in earnings estimates over the past 60 days. DENTSPLY SIRONA, a medical devices company, saw an 11% downward revision. Dutch Bros, a drive-thru restaurant operator, experienced a 5.2% downward revision. Great Elm Capital Corp., a business development company, faced a 5.5% downward revision.
Dentsply International reported Q3 2026 revenue of $836 million, down 7.5% year-over-year and missing Wall Street's consensus estimate of $855.98 million by 2.34%. EPS came in at $0.29 versus the estimated $0.30, representing a 3.33% miss. Key business segments showed mixed results, with Americas sales beating estimates but Connected Technology Solutions and Orthodontic and Implant Solutions significantly underperforming. The stock carries a Zacks Rank #4 (Sell) rating.
The ANZ dental implants market is valued at USD 266.0 million in 2025 and is projected to reach USD 393.0 million by 2033, growing at a 5.0% CAGR. Growth is driven by aging populations, increased demand for prosthetics, and technological advances in implant materials. However, high treatment costs remain a significant barrier to market expansion, with 28% of Australians delaying dental care due to affordability concerns.
Dentsply Sirona announced an expanded distribution agreement with Midwest Dental Equipment & Supply effective November 1, 2026, to offer its digital dentistry technology portfolio across the U.S. This marks the company's seventh North American dealer partnership enhancement in 2026, aimed at broadening access to connected technology solutions and accelerating digital dentistry adoption. XRAY stock gained 3.6% following the announcement.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Dec 26, 2025
$0.16
Jan 9, 2026
recurring
Sep 26, 2025
$0.16
Oct 10, 2025
recurring
Jun 27, 2025
$0.16
Jul 11, 2025
recurring
Mar 28, 2025
$0.16
Apr 11, 2025
recurring
Dec 27, 2024
$0.16
Jan 10, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.